The impact of Amphetamine-Related Disorders on community psychiatric emergency services: 1993-1997

American Journal on Addictions

Volumn 9, Issue 1, 2000, Pages 70-78

  Leamon, Martin H ^a   Canning, Robert D ^b   Benjamin, Lloyd ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE;

ADULT; ARTICLE; DRUG ABUSE; DRUG INDUCED DISEASE; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SOCIAL PSYCHIATRY;

EID: 0034096770     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/10550490050172245     Document Type: Article

References (31)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Mid-year 1997 preliminary emergency department data from the Drug Abuse Warning Network, Table 41. Estimated rate of emergency department methamphetamine / speed mentions per 100,000 population, by metropolitan area by half-year, second half 1991-first half 1997. Available at: http:// www.samhsa.gov/oas/dawn/dawnmidyr/httoc.ht m. Accessed November, 1998.
2. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National admissions to substance abuse treatment services: the Treatment Episode Data Set (TEDS), 1992-1996, Table 2.3. Number and percent distribution of admissions by primary substance of abuse: TEDS 1991-1996. Available at: http:/www. samhsa.gov/oas/teds/Teds96htm/Intro.htm. Accessed November, 1998.
3. Community Epidemiology Work Group. Epidemiologic trends in drug abuse, advance report, June 1998. Available at: http://www.cdmgroup.com/ cewg/docs/698-boston/698adv.htm. Accessed November, 1998.
4. Office of National Drug Control Policy. Data snapshot: drug abuse in America - August 1998, Slides 40-45. Available at: http://www.whitehousedrug policy.gov/drugfact/aug98/toc.html. Accessed November, 1998.
5. Weaver R. Intelligence: Trafficking Organizations. Office of National Drug Control Policy. The National Methamphetamine Drug Conference Proceedings. Washington, DC: Office of National Drug Control Policy; 1998:29-34.
6. Heischober B, Miller MA. Methamphetamine abuse in California. In: Miller MA, Kozel NJ, eds. Methamphetamine Abuse: Epidemiologic Issues and Implications. Research Monograph 115. Rockville, Md: U.S. Department of Health and Human Services, National Institute on Drug Abuse; 1991:60-71.
7. California Department of Justice. Stop drugs opening page. Available at: http://www.stop drugs.org/mainindex.html. Accessed November, 1998.
8. State of California Department of Alcohol and Drug Programs. Facts and Figures on Alcohol and Other Drugs. Sacramento, Calif: California Department of Alcohol and Drug Programs; 1996.
9. Cunningham JK, Thielemeir MA. Amphetamine-Related Emergency Admissions: Trends and Regional Variations in California (1995-1994). Irvine, Calif: Public Statistics Institute; 1996.
10. Lungren, D. California Attorney General Lungren Letter; February 27, 1998. Available at: http:// www.caag.state.ca.us/letters/98-03.htm. Accessed November, 1998.
11. Wiegand S. Use of methamphetamine speeds upwards in California. Sacramento Bee. January 12, 1997: A1.
12. Anderson R, Flynn N. The methamphetamine-HIV connection in northern California. Klee H, ed. Amphetamine Misuse: International Perspectives on Current Trends. Singapore: Harwood Academic Publishers/Gordon and Breach Science Publishers; 1997:181-196.
13. Morgan P. Researching hidden communities: a quantitative comparative study of methamphetamine use in three sites. Epidemiologic Trends in Drug Abuse, December 1993. Rockville, Md: U.S. Department of Health and Human Services, National Institute on Drug Abuse; 1994:402-410.
14. Johnson J, Milner G. Psychiatric complications of amphetamine substances. Acta Psychiatr Scand. 1966;42:252-263.
15. Snyder SH. A "model schizophrenia" mediated by catecholamines. Smith DE, Wesson DR, et al., eds. Amphetamine Use, Misuse and Abuse. Boston, Mass: G. K. Hall; 1979:189-204.
16. Ellinwood EH. Amphetamine psychosis: a multidimensional process. Semin Psychiatry. 1969;1(2): 208-226.
17. Kalant O.J. Amphetamine psychosis. In: The Amphetamines: Toxicity and Addiction. 2nd ed. Toronto: University of Toronto Press; 1973:37-76.
18. Szuster RR, Schanbacher BL, McCann SC. Characteristics of psychiatric emergency room patients with alcohol-or drug-induced disorders. Hosp Community Psychiatry. 1990;41:1342-1345.
19. Baberg HT, Nelesen RA, Dimsdale JE. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry. 1996;153: 789-793.
20. th Annual Medical-Scientific Conference. J Addict Dis. 1997; 16(2):112.
21. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Mid-year 1997 preliminary emergency department data from the Drug Abuse Warning Network, Table 27. Estimated rate of emergency department methamphetamine / speed mentions, by age, sex, race/ ethnicity, hospital location, drug use motive, and reason for emergency department visit, second half 1991-first half 1997. Available at: http:// www.samhsa.gov/oas/dawn/dawnmidyr/httoc.ht m. Accessed November, 1998.
22. California State Department of Finance Demographic Research Unit. Race/ethnic population estimates. Available at: http://www.dof.ca.gov/ html/Demograp/race-eth.htm. Accessed November, 1998.
23. California State Department of Finance Demographic Research Unit. Population estimates for California state and counties. Available at: http:// www.dof.ca.gov/html/Demograp/e-2text.htm. Accessed November, 1998.
24. County of Sacramento, Office of Communications & Information Technology. An informative look at Sacramento county. Available at: http://www. co.sacramento.ca.us/economic/broone.html. Accessed November, 1998.
25. Roche Diagnostic Systems. Abuscreen ONTRAK Package Insert.
26. Newmeyer JA. The barefoot epidemiologist: "what works" in drug abuse prevalence estimation. J Addict Dis. 1991;11:61-69.
27. Office of National Drug Control Policy. 1998 National Drug Control Policy. Washington, DC: White House Office of National Drug Control Policy; 1998.
28. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Highlights, Drug Abuse Warning Network series: year-end preliminary estimates from the 1996 Drug Abuse Warning Network. Available at: http://www. samhsa.gov/oas/dawn/dwn96006.htm#E11E6. Accessed November, 1998.
29. Hien D, Zimberg S, Weisman S, et al. Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatric Services. 1997; 48:1058-1063.
30. Mueser KT, Drake RE, Miles KM. The course and treatment of substance use disorder in persons with severe mental illness. Onken LS, Schultz T, eds. Treatment of Drug-Dependent Individuals with Comorbid Mental Disorders. NIDA Research Monograph 172. Rockville, Md: National Institutes of Health; 1997:86-109.
31. Osher FC, Drake RE, Green VL, et al. Special section: approaches to care for persons with co-occurring addictive and mental disorders. Am J Orthopsychiatry. 1996;66:4-76.